Skip to main content
. 2023 Sep 27;43(39):6619–6627. doi: 10.1523/JNEUROSCI.0625-23.2023

Figure 1.

Figure 1.

Experimental design. A, Monkeys received AAV-PSAM4 vector injections into the striatum (n = 2 monkeys) and primary motor cortex (MI; n = 1). B, [18F]ASEM-PET was performed to visualize PSAM4 expression in vivo. C, After administering uPSEMs, activation mapping using [18F]FDG-PET imaging allowed the relationship between agonist type/dose and activation strength to be determined. D, Pharmacological MRI was used to measure the time course of chemogenetically induced activity changes.